Perry Johnson & Associates Medical Transcription

This docket consolidates claims arising from a data security breach at Perry Johnson & Associates, a medical transcription services vendor whose systems were compromised, exposing personal and health information belonging to patients of the numerous healthcare providers and hospital systems that used its transcription services. Centralized in the Eastern District of New York in early 2024, the docket carries 57 pending actions, reflecting a vendor-breach structure similar to other healthcare-sector data-security litigation in this docket type.

For a funder, the central diligence question mirrors other medical-vendor breach dockets: identifying which downstream healthcare provider's patients are implicated for a given claim and what categories of protected health information were exposed, since Perry Johnson's transcription services touched a range of provider types with differing data-sensitivity profiles. Standing and damages-methodology arguments for healthcare-sector data-breach claims are reasonably well developed as a category given the volume of prior medical-vendor breach MDLs, which provides useful comparative context even as this docket develops its own specific settlement or resolution framework.

Because this is a data-exposure matter rather than a medical-treatment matter, medical-lien considerations in the traditional sense do not apply, notwithstanding the healthcare context of the underlying data. For a claimant group or firm with claims tied to patients of a specific provider affected by this breach, Criterica Capital's commercial litigation finance line is the applicable structure, with diligence focused on the specific provider relationship and exposed data category. A structural brief on this docket is available through Criterica Intelligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.